Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CBDD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -1.683M
March 31, 2026 -1.631M
December 31, 2025 -1.598M
September 30, 2025 -1.478M
June 30, 2025 -1.359M
March 31, 2025 -1.341M
December 31, 2024 -1.336M
September 30, 2024 -1.518M
June 30, 2024 -1.486M
March 31, 2024 -1.449M
December 31, 2023 -1.352M
September 30, 2023 -1.994M
June 30, 2023 -1.913M
March 31, 2023 -1.874M
December 31, 2022 -1.969M
September 30, 2022 -0.2517M
June 30, 2022 -0.2882M
March 31, 2022 -0.1753M
December 31, 2021 0.2477M
September 30, 2021 1.513M
June 30, 2021 1.978M
March 31, 2021 1.897M
December 31, 2020 0.7984M
September 30, 2020 1.342M
June 30, 2020 0.5021M
Date Value
March 31, 2020 -0.7307M
December 31, 2019 -0.5852M
September 30, 2019 -0.9763M
June 30, 2019 -0.9618M
March 31, 2019 -0.9001M
December 31, 2018 -0.9225M
September 30, 2018 -1.826M
June 30, 2018 -1.826M
March 31, 2018 -1.822M
December 31, 2017 -1.817M
September 30, 2017 -1.821M
June 30, 2017 -1.819M
March 31, 2017 -1.817M
December 31, 2016 -1.815M
September 30, 2016 -1.813M
June 30, 2016 -1.811M
March 31, 2016 -1.809M
December 31, 2015 -1.566M
September 30, 2015 -1.566M
June 30, 2015 -1.573M
March 31, 2015 -1.573M
December 31, 2014 -0.317M
September 30, 2014 -1.663M
June 30, 2014 -1.553M
March 31, 2014 -1.398M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Global PVQ SE --
Bespoke Extracts, Inc. -2.596M
Entia Biosciences, Inc. --
Bright Green Corp. --
Carisma Therapeutics, Inc. -0.867M

Shareholders Equity (Quarterly) Related Metrics